Ozempic® Sulfur Burps, Gas, and Bloating: Why GLP-1 Medications Cause the “Food-Stuck” Feeling
- Joshua Silva, MD
- Jan 26
- 8 min read
Updated: 5 days ago
Medically authored by Joshua Silva, MD | Evidence-Based Weight Loss at Potere Health MD
Many people taking GLP-1 receptor agonists such as semaglutide (Ozempic®, Wegovy®) or tirzepatide (Mounjaro®, Zepbound®) experience digestive symptoms including bloating, sulfur-smelling burps, excess gas, early satiety, or a heavy sensation that food feels “stuck” after meals. These effects are most commonly caused by delayed gastric emptying, an intentional pharmacologic action of GLP-1 medications that supports appetite suppression and weight loss.¹,²
Jump to:
What sulfur burps and bloating are on GLP-1 medications
Why food feels “stuck” on Ozempic® or Wegovy®
Why gas and bloating occur on GLP-1 therapy
Foods that worsen sulfur burps and bloating
6 practical ways to reduce symptoms
What are sulfur burps and bloating on GLP-1 medications like Ozempic® and Wegovy®
Sulfur burps and bloating on GLP-1 medications are upper gastrointestinal side effects caused by delayed gastric emptying, resulting in foul-smelling burps, abdominal fullness, gas, and early satiety.¹–³

How patients commonly describe this symptom pattern
Burps with a sulfur or “rotten egg” taste or smell
A bloated or overly full feeling after small meals
Feeling full after only a few bites (early satiety)
Upper-abdominal pressure or discomfort
Excess gas or frequent belching
Fullness that lasts hours after eating²,³
Why do GLP-1 medications such as semaglutide and tirzepatide cause sulfur burps and bloating?
GLP-1 medications cause sulfur burps and bloating by slowing gastric emptying, which keeps food in the stomach longer and increases pressure and post-meal discomfort, especially after larger or higher-fat meals.¹–³
Scientific explanation — delayed gastric emptying and pyloric tone
GLP-1 receptor agonists reduce gastric motility and increase pyloric sphincter tone, delaying the passage of solid food from the stomach into the small intestine. This improves post-prandial glucose control and satiety, but prolonged gastric retention can increase distension and contribute to bloating, pressure, and sulfur-smelling burps.¹–³
Plain-English explanation — why food stays in the stomach longer
In simple terms, GLP-1 medications tell the stomach to slow down. Food stays in the stomach longer than usual, so fullness lasts longer. When meals are larger, higher in fat, or heavier, that slower movement can feel uncomfortable, causing bloating or unpleasant burping even though digestion continues normally.¹–³
Feature | Scientific Mechanism | Plain-English Explanation |
Why it happens | Delayed gastric emptying with reduced motility and increased pyloric tone | The stomach “slows down,” keeping food inside longer |
The result | Prolonged gastric retention and distension | A heavy, “stuck” feeling and bloating |
Why burps smell sulfur-like | Prolonged gastric retention may increase fermentation of food contents | Burps can smell like sulfur or “rotten eggs” |
When sulfur burps and bloating are less likely to occur on GLP-1s
Sulfur burps and bloating are less likely when:
Meal portions are smaller and eaten more slowly
High-fat meals are limited, especially restaurant or buffet foods
Protein portions are moderate rather than very dense
The body has adapted after early treatment or dose increases
Individual trigger foods are identified and avoided
Eating stops at early satiety, not fullness²,³
Why does food feel “stuck” on Ozempic® or Wegovy®?
Food can feel “stuck” on Ozempic® or Wegovy® because GLP-1 medications delay gastric emptying, allowing meals to remain in the stomach longer than usual.
This prolonged retention increases pressure, fullness, and discomfort, especially after larger, protein-dense, or high-fat meals, even though digestion continues normally and food is not physically blocked.¹–³
Large meal volume and gastric distension
Larger meal volumes cause the stomach to stretch. When gastric emptying is slowed by GLP-1 medications, this gastric distension lasts longer, leading to pressure, bloating, and prolonged fullness. Even moderate portions may feel heavy when food remains in the stomach for extended periods.¹–³
Protein-dense meals and prolonged gastric processing
Protein-dense foods naturally take longer to break down in the stomach. On GLP-1 therapy, this normal processing time is further prolonged, which can make protein-heavy meals feel unusually heavy or uncomfortable, contributing to the sensation that food is lingering.¹–³
High-fat meals and physiologic slowing of digestion
Dietary fat slows gastric emptying through normal physiologic feedback. When combined with GLP-1–mediated slowing, high-fat meals can significantly delay stomach emptying, worsening fullness, nausea, and the feeling that food is “stuck,” particularly after restaurant or buffet-style meals.¹–³
Why do GLP-1 medications like Ozempic® and Wegovy® cause gas and bloating?
GLP-1 medications like Ozempic® and Wegovy® can cause gas and bloating by slowing digestion, which increases the time carbohydrates remain in the gastrointestinal tract and allows greater microbial fermentation. This process produces gas that can lead to abdominal distension, bloating, and pressure, even though digestion and absorption remain normal.⁶,⁷
Scientific explanation — fermentation and slower transit time
Gas in the gastrointestinal tract is primarily produced by microbial fermentation of carbohydrates. When GLP-1 medications slow gastrointestinal transit, fermentable carbohydrates remain exposed to gut microbes longer, increasing gas and bloating in susceptible individuals. Randomized trials in non-GLP-1 populations show that reducing carbohydrate fermentation lowers breath hydrogen and gas-related symptoms, supporting this mechanism.⁴,⁵
Plain-English explanation — why carbs “sit longer” and make more gas
In simple terms, slower digestion gives gut bacteria more time to work on carbohydrates. As those carbs sit longer, bacteria produce more gas. This can lead to bloating, pressure, or frequent belching, even when meals are small and digestion is otherwise normal.⁵
When gas is less likely on GLP-1 medications (misconceptions and nuance)
Gas and bloating are less likely when:
Meals are lower in fermentable carbohydrates
Portion sizes are smaller and evenly spaced
Eating is slower, with thorough chewing
Carbonated beverages are limited
The body has adapted over time on a stable dose
Individual gas-trigger foods are identified⁴,⁵
What foods worsen gas, bloating, and sulfur burps on GLP-1 medications?
Foods that worsen gas, bloating, and sulfur burps on GLP-1 medications are typically large, high-fat, or highly fermentable meals, which are more likely to exacerbate delayed gastric emptying and microbial gas production. Symptoms are most noticeable after restaurant meals, buffet eating, or rapid consumption of dense foods.¹–³
Foods more likely to worsen symptoms include:
Fermentable carbohydrates (beans, lentils, broccoli, cauliflower, onions)
High-fat meals, especially fried foods and creamy sauces
Large portion sizes, even of otherwise healthy foods
Restaurant or buffet meals with higher fat and calorie density
Carbonated beverages that increase stomach distension
Rapid eating without stopping at early satiety¹,²,⁶–⁹
Fermentable carbs (beans, crucifers, onions)
Common fermentable carbohydrate sources include:
Beans and lentils
Broccoli and cauliflower
Onions and garlic
Cabbage and Brussels sprouts
Large servings of whole grains or legumes⁴,⁵
High-fat restaurant meals and large portions
Meals eaten outside the home are often higher in fat, calories, and portion size than home-prepared meals. Larger meal volume and higher energy density slow gastric emptying, and when combined with GLP-1–mediated slowing, this can amplify post-meal fullness, bloating, and discomfort.⁶–⁹
Carbonation and rapid eating
Behaviors that can amplify bloating and gas include:
Soda, sparkling water, or beer
Drinking carbonated beverages with meals
Eating quickly or while distracted
Continuing to eat past early fullness
Skipping pauses between bites¹,²
Does simethicone (Gas-X®) help sulfur burps, bloating, or gas on GLP-1 medications?
Simethicone is generally effective for gas and bloating but ineffective for sulfur burps caused by GLP-1 medications. While it breaks up gas bubbles to relieve pressure, it does not neutralize sulfur odors or fix the delayed gastric emptying associated with drugs like Semaglutide and Tirzepatide.
Bloating & Gas: Yes. It acts as an antifoaming agent to break up trapped bubbles and relieve abdominal pressure.
Sulfur Burps: No. It does not neutralize sulfur odors or address the food fermentation causing the smell.
How long do sulfur burps and bloating last on GLP-1 medications?
Sulfur burps and bloating on GLP-1 medications most often occur early in treatment or after dose increases, with many patients improving as the body adapts over weeks to months. Others may experience intermittent symptoms depending on meal size, composition, and individual sensitivity to delayed gastric emptying.²,³
Clinical note: In real-world clinical practice, acute episodes triggered by a specific meal often resolve within 24 hoursas gastric emptying progresses. Persistent or worsening symptoms warrant further evaluation.
Early treatment vs dose escalation patterns
Timing on GLP-1 therapy | Symptom pattern |
First weeks of treatment | Bloating and burps more common |
After dose increases | Temporary symptom worsening |
Stable dose over time | Gradual improvement for many |
Trigger meals | Intermittent symptom recurrence |
Why symptoms improve in some patients but persist in others
Symptom patterns vary because of differences in gastric sensitivity, meal composition, eating behaviors, and individual response to GLP-1–mediated motility changes. Clinical trials report gastrointestinal effects, but real-world experiences differ, and not all patients adapt at the same pace.²,³
What 6 tips help reduce sulfur burps and bloating on GLP-1 medications (without supplements)?
These strategies can help:
Reduce portion size to limit gastric distension
Eat slowly and pause between bites
Stop at early satiety, not fullness
Limit high-fat meals, especially when eating out
Identify trigger foods and adjust accordingly
Space meals evenly rather than eating large volumes at once¹–³
When should sulfur burps or bloating on Ozempic® prompt medical evaluation?
Medical evaluation is appropriate when sulfur burps or bloating on GLP-1 medications are severe, persistent, or worsening, particularly if symptoms interfere with nutrition, hydration, or daily functioning. Additional warning signs include vomiting, significant abdominal pain, or failure to improve with dietary adjustments.
Medical evaluation is appropriate if symptoms:
Are severe, persistent, or worsening
Are accompanied by vomiting or dehydration
Cause significant abdominal pain
Interfere with nutrition or daily function
Do not improve despite diet and portion adjustments
Occur with new or concerning gastrointestinal symptoms
Bottom line — sulfur burps and bloating on GLP-1 medications
Sulfur burps and bloating on GLP-1 medications are common digestive side effects driven by delayed gastric emptying, not abnormal digestion. Symptoms often relate to meal size, fat content, and eating pace, and many patients improve with time and behavioral adjustments. Persistent or severe symptoms should prompt discussion with a prescribing clinician.¹–³
Disclaimer
This article is for educational purposes only and is not a substitute for medical advice.
About the Author
Dr. Joshua Silva, MD, is a licensed physician and Medical Director of Potere Health MD. He earned his medical degree from the University of Hawaiʻi John A. Burns School of Medicine and completed residency training in Occupational and Environmental Medicine at the University of Utah, where he also earned a master’s degree in Occupational Health. He later completed a Master of Business Administration with an emphasis in health care administration at Ohio University.
Dr. Silva specializes in evidence-based weight management and routinely manages GLP-1 therapy and related digestive side effects for patients at Potere Health MD in St. George, Utah. He provides physician-led care focused on medication tolerability, long-term metabolic outcomes, and safe, sustainable weight loss through both in-person and telehealth visits across Southern and Northern Utah.
References
Jalleh RJ, Plummer MP, Marathe CS, et al. Clinical consequences of delayed gastric emptying with GLP-1 receptor agonists and tirzepatide. J Clin Endocrinol Metab. 2024;110(1):1-15. https://pubmed.ncbi.nlm.nih.gov/39418085/
Filippatos TD, Panagiotopoulou TV, Elisaf MS. Adverse effects of GLP-1 receptor agonists. Rev Diabet Stud.2014;11(3-4):202-230. https://pmc.ncbi.nlm.nih.gov/articles/PMC5397288/
Camilleri M, et al. Effects of GLP-1 and other gut hormone receptors on the gastrointestinal tract and implications in clinical practice. Clin Gastroenterol Hepatol. Published 2024. Accessed January 22, 2026.https://pubmed.ncbi.nlm.nih.gov/37753925/
Di Stefano M, Miceli E, Missanelli A, Mazzocchi S, Corazza GR. The effect of oral α-galactosidase on intestinal gas production and gas-related symptoms. Dig Dis Sci. 2007;52:78-83. https://pubmed.ncbi.nlm.nih.gov/17151807/
Di Nardo G, Oliva S, Ferrari F, et al. Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: a randomized, double-blind, placebo-controlled trial. BMC Gastroenterol. 2013;13:142. https://link.springer.com/article/10.1186/1471-230X-13-142
Todd JE, Mancino L, Lin BH. The impact of food away from home on adult diet quality. USDA Economic Research Service. 2010. https://www.ers.usda.gov/publications/pub-details/?pubid=46354
Cohen DA, Bhatia R. Nutrition standards for away-from-home foods. Am J Prev Med. 2012;43(3):e11-e18. https://pmc.ncbi.nlm.nih.gov/articles/PMC3380140/
Rolls BJ, Morris EL, Roe LS. Portion size of food affects energy intake. Am J Clin Nutr. 2002;76(6):1207-1213. https://pubmed.ncbi.nlm.nih.gov/12450884/
Hunt JN, Stubbs DF. The volume and energy content of meals as determinants of gastric emptying. J Physiol.1975;245(1):209-225. https://pmc.ncbi.nlm.nih.gov/articles/PMC1330851/




Comments